Skip to main content
Log in

A Practical Guide for Calculating Indirect Costs of Disease

  • Review Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

There may be some discussion about whether indirect costs should be taken into account at all in an economic appraisal, but there is certainly considerable debate about the proper way of estimating these costs.

This reviews offers a practical guide for quantifying and valuing these indirect costs of disease, both at an aggregated level of general cost of illness studies, and in an economic appraisal of specific healthcare programmes.

Two methods of calculating these costs are considered: the traditional human capital approach, and the more recently developed friction cost method. The former method estimates the potential value of lost production as a result of disease, whereas the latter method intends to derive more realistic estimates of indirect costs, taking into account the degree of scarcity of labour in the economy. All necessary steps in the estimation procedure and the data required at various points will be described and discussed in detail.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Draft guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analyses. Canberra: Commonwealth of Australia, 1995

  2. Guidelines for economic evaluation of pharmaceuticals. 1st ed. Ottawa, Canada: CCOHTA, 1994

  3. Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. The friction cost method for estimating the indirect costs of disease. J Health Econ 1995; 14: 171–89

    Article  PubMed  CAS  Google Scholar 

  4. Koopmanschap MA, Rutten FFH. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 1993; 4: 446–54

    Article  PubMed  CAS  Google Scholar 

  5. Drummond MF. Cost-of-illness studies: a major headache? Pharmacoeconomics 1992; 2: 1–4

    Article  PubMed  CAS  Google Scholar 

  6. Gerard K, Donaldson C, Maynard AK. The cost of diabetes. Diabet Med 1989; 6: 164–70

    Article  PubMed  CAS  Google Scholar 

  7. Lindgren B. Costs of illness in Sweden 1964–1975. Lund: Liber, 1981

    Google Scholar 

  8. Williams A. Economics of coronary artery bypass grafting. BMJ 1985; 291: 326–9

    Article  PubMed  CAS  Google Scholar 

  9. de Koning J, Tuyl FAWM. The relation between labour time, production and employment [In Dutch]. Rotterdam: Netherlands Economic Institute, 1984

    Google Scholar 

  10. van Roijen L, Essink-Bot ML, Koopmanschap MA, et al. Labour and health status in economic evaluation of health care: the health and labour questionnaire. Int J Technol Assess Health Care. In press

  11. van Ours J, Ridder G. Cyclical variation in vacancy durations and vacancy flows, an empirical analysis. Eur Econ Rev 1991; 35: 1143–55

    Article  Google Scholar 

  12. Koopmanschap MA, Rutten FFH. The impact of indirect costs on outcomes of health care programs. Health Econ 1994; 3: 385–93

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc A. Koopmanschap.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koopmanschap, M.A., Rutten, F.F.H. A Practical Guide for Calculating Indirect Costs of Disease. Pharmacoeconomics 10, 460–466 (1996). https://doi.org/10.2165/00019053-199610050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199610050-00003

Keywords

Navigation